Crossmark

Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?

Crossref DOI link: https://doi.org/10.1038/gim.2014.79

Published Print: 2015-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pisani, Antonio

Riccio, Eleonora

Sabbatini, Massimo
License Information

Text and Data Mining valid from 2015-01-01

Text and Data Mining valid from 2015-01-01

Version of Record valid from 2021-11-24
More Information

This article is maintained by: Elsevier

Article Title: Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/gim.2014.79

Content Type: article

Copyright: © 2015, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics